80 Participants Needed

High Fiber Diet for Lung Cancer

Recruiting at 1 trial location
WB
Overseen ByWiam Belkaid, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Must be taking: Immune checkpoint inhibitors
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a high-fiber diet can enhance the effects of immune checkpoint inhibitors—medicines that help the immune system fight cancer—in people with non-small cell lung cancer (NSCLC). Participants will either maintain their usual diet or receive guidance to increase fiber intake as part of a dietary intervention. The goal is to determine if more fiber can improve the effectiveness of cancer treatment. Individuals with NSCLC who are on immune checkpoint inhibitors and can eat solid foods may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve cancer treatment outcomes.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this dietary intervention is safe for patients with non-small cell lung cancer?

Research shows that a high-fiber diet is generally safe and beneficial. Studies have found a link between increased fiber intake and a lower risk of lung cancer. Specifically, individuals who consumed a lot of fiber had a 33% lower chance of developing lung cancer.

Other research suggests that fiber might improve outcomes for various types of cancer. Some studies found that patients who consumed more fiber responded better to certain cancer treatments.

Overall, most people can increase their fiber intake without issues. No major reports of serious side effects from consuming more fiber exist. However, some individuals might experience mild digestive issues, such as bloating or gas, when they first increase their fiber intake. Gradually adding more fiber to the diet can help reduce these effects.12345

Why are researchers excited about this trial?

Researchers are excited about the high fiber diet being studied for lung cancer because it offers a non-drug approach to potentially improve patient outcomes. Unlike the standard treatments for lung cancer, which often involve chemotherapy, radiation, or targeted therapies, this dietary intervention focuses on increasing fiber intake, which is believed to enhance gut health and possibly boost the immune response. The method is simple, involving dietary changes and counseling, making it an accessible option that could complement existing treatments. This novel approach might provide additional benefits without the side effects typically associated with traditional cancer treatments.

What evidence suggests that this dietary intervention is effective for non-small cell lung cancer?

Research shows that a high-fiber diet can help lung cancer patients respond better to treatment. In this trial, participants in the intervention group will receive counseling to increase their total fiber intake. Studies have found that dietary advice helps patients maintain stable weight and a healthy diet, which can improve treatment outcomes. Increased fiber intake is also linked to better responses to immune checkpoint inhibitors, a common treatment for non-small cell lung cancer. Additionally, a high-fiber diet is associated with a lower risk of developing lung cancer, regardless of other risk factors. Early findings suggest that a high-fiber diet might also enhance responses to standard immunotherapy for other cancer types.45678

Who Is on the Research Team?

BR

Bertrand Routy, MD,PhD

Principal Investigator

CHUM

Are You a Good Fit for This Trial?

This trial is for adults over 18 with confirmed non-small cell lung cancer (NSCLC) who are being treated with standard immune checkpoint inhibitors and can eat solid foods. It's not suitable for those with severe dietary allergies or psychiatric/substance abuse issues that could affect participation.

Inclusion Criteria

Signed, informed consent
I have been diagnosed with non-small cell lung cancer and am treated with standard immune checkpoint inhibitors.
You can eat solid foods.

Exclusion Criteria

Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
You have severe allergies to certain foods like shellfish, nuts, or seafood.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention

12 weeks
3 visits (in-person) at baseline, 6 weeks, and 12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Dietary Intervention
Trial Overview The study is testing if increasing total fiber intake affects the effectiveness of standard immune therapy in NSCLC patients. Participants will either continue their normal diet or follow a high-fiber diet alongside their regular cancer treatment.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Centre hospitalier de l'Université de Montréal (CHUM)

Lead Sponsor

Trials
389
Recruited
143,000+

Published Research Related to This Trial

High fiber consumption is generally associated with lower colon cancer rates in humans, particularly from cereal fiber sources, although case-control studies do not consistently confirm a protective effect from dietary fiber alone.
Laboratory studies indicate that poorly fermentable fibers like wheat bran may protect against colon cancer, while some fermentable fibers can actually enhance tumor development, suggesting that the type of fiber and its properties play a crucial role in cancer risk.
Relationship between dietary fiber and cancer: metabolic, physiologic, and cellular mechanisms.Jacobs, LR.[2020]
Inclusion of dietary fiber, specifically soft white wheat bran, significantly reduced the incidence and number of mammary carcinomas in female Sprague-Dawley rats during the promotion stage of carcinogenesis induced by DMBA.
A diet with 9.6% fiber not only decreased the development of mammary tumors in ovariectomized rats but also showed promising results in reducing tumor growth in virgin mice, indicating the potential of dietary fiber in cancer prevention across different animal models.
Effect of wheat bran fiber on the development of mammary tumors in female intact and ovariectomized rats treated with 7,12-dimethylbenz(a)anthracene and in mice with spontaneously developing mammary tumors.Zile, MH., Welsch, CW., Welsch, MA.[2019]
A diet high in dietary fiber, particularly from wheat bran, is associated with a reduced risk of colon cancer, as shown in various studies including case-control and animal models.
Wheat bran specifically inhibits colon tumor development more effectively than other fiber sources like oat and corn bran, and it reduces levels of tumor promoters in the colon, highlighting its potential as a protective dietary component.
Role of dietary fiber in colon cancer: an overview.Reddy, BS.[2019]

Citations

Dietary Counseling Outcomes in Patients with Lung ...Conclusions: Dietary counseling helps to maintain body weight, maintain dietary intake, and enhance treatment responses in lung cancer patients ...
High Fiber Diet for Lung CancerWhat data supports the effectiveness of the treatment 'High Fiber Diet for Lung Cancer'? Research suggests that nutritional counseling and a diet rich in fiber ...
The DIET study: A randomized controlled trial of a high ...Habitual high dietary fiber intake is associated with improved response to ICB and high fiber diet interventions have been shown to favorably ...
Association of Dietary Fiber and Yogurt Consumption With ...High intakes of dietary fiber or yogurt were individually associated with reduced risk of lung cancer, independent of all known risk factors.
High-Fiber Diet May Improve Response to ImmunotherapyA high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.
Association of Dietary Fiber and Yogurt Consumption With ...Individuals who reported high yogurt consumption with the highest quintile of fiber intake had a 33% reduced lung cancer risk (95% CI, 0.61-0.73) ...
Diet and Risk of Incident Lung CancerThese results further confirm that fruits, vegetables, breakfast cereals, and dietary fiber may prevent the development of lung cancer, whereas red meat and ...
Dietary fiber consumption and outcomes of different cancersHigher dietary fiber intake is linked to reduced cancer risk and improved outcomes. These findings highlight dietary fiber's importance in ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security